Collectively, we suggest a model in which PLCL1 promotes tumor cell “slimming” by increasing the level of UCP1, allowing cells to consume lipids without producing ATP to repress the progression of ccRCC (Figure 7G). Here, PLCL1 is linked to nonpapillary renal cell carcinoma.